Table 2.
Medications Used Regularly by the Study Participants (Number of Participants With Each Type of Medication)
| Medication | Men (n=167) | Women (n=167) |
|---|---|---|
| Acetylsalicylic acid | 3 | 0 |
| Acyclovir | 0 | 1 |
| Allopurinol | 0 | 1 |
| Amitriptyline | 0 | 1 |
| Amoxicillin | 0 | 1 |
| Antidepressant (SSRI or SNRI) | 3 | 12 |
| Antihistamine | 2 | 5 |
| Doxycycline (low dose) | 1 | 0 |
| Ezetimibe | 1 | 0 |
| Female hormones | ||
| Systemic (including tibolone) | 0 | 41 |
| Topical | 0 | 3 |
| Glucosamine | 3 | 3 |
| Intranasal or inhaled corticosteroid | 2 | 6 |
| Isotretinoin | 0 | 1 |
| Letrozole | 0 | 1 |
| Levomepromazine | 0 | 1 |
| Levonorgestrel via intrauterine device | 0 | 16 |
| Liothyronine | 0 | 1 |
| Lymecycline | 1 | 0 |
| Mefloquine | 0 | 1 |
| Melatonin | 1 | 1 |
| Mepacrine | 1 | 0 |
| Nonsteroidal anti‐inflammatory drug | 1 | 3 |
| Oxybutynine | 0 | 1 |
| Pramipexole | 0 | 1 |
| Pregabalin | 1 | 1 |
| Proton pump inhibitor | 3 | 4 |
| Quetiapine | 0 | 1 |
| Statin | 7 | 1 |
| Thyroxine | 0 | 10 |
| Valproate | 0 | 1 |
| Vitamin D supplementation | 6 | 11 |
| Warfarin | 1 | 0 |
SNRI indicates serotonin–norepinephrine reuptake inhibitor; SSRI, selective serotonin reuptake inhibitor.